Literature DB >> 21472128

Is spleen circulation impaired in systemic sclerosis and what is the role of liver fibrosis?

Giovanni Tarantino1, Angelo Spanò, Gabriella Loi, Anna Parisi, Marianna Tarantino, Giuseppina Brancaccio, Giovanni Battista Gaeta, Antonio Riccio.   

Abstract

AIM: To investigate the spleen vascular involvement and the presence of liver fibrosis in a population of subjects with established systemic sclerosis (SSc).
METHODS: In a cross-sectional fashion, 17 patients with SSc were compared with 18 patients suffering from hepatitis C virus (HCV)-related liver cirrhosis, grade A and B Child-Pugh classification. Eighteen non elderly subjects, apparently healthy, were used as the control group. Splenic artery resistivity index (SARI) at Doppler ultrasound, transient elastography of liver and nailfold capillaroscopy were the main outcomes.
RESULTS: Transient elastography values of SSc patients were similar to those of controls; 5.2 ± 1.1 vs 4.5 ± 1, (P = 0.07). Median Alanine amino transferase (ALT) concentrations of cirrhotic patients were greater than those of controls and SSc patients, i.e. 66.5 (36-89) U/L vs 29 (22-34) U/L and 31 (22-41) U/L, respectively, (P = 0.005). SARI determinations in cirrhotic patients, although significantly higher than those found in controls and SSc patients, showed some degree of overlap with SSc patients, i.e. 0.59 vs 0.52 and 0.57, respectively, (P = 0.04). Mean systolic blood pressure was significantly higher in SSc patients than in cirrhotics and controls, i.e. 142 mmHg vs 128.2 mmHg and 127 mmHg, respectively, (P = 0.005). Mean diastolic blood pressure behaved in a similar fashion, i.e. 84 mmHg vs 72.2 mmHg and 76.9 mmHg (P = 0.005). Nailfold Capillaroscopy grades and diastolic blood pressure values correlated well with SARI results.
CONCLUSION: An enhanced resistivity of the splenic artery was found in patients suffering from SSc; they did not have evidence of splenomegaly as well as no liver fibrosis or any other form of liver damage.

Entities:  

Keywords:  Doppler ultrasound; Liver fibrosis; Nailfold capillaroscopy; Splenic artery resistivity index; Systemic sclerosis; Transient elastography

Mesh:

Year:  2011        PMID: 21472128      PMCID: PMC3070133          DOI: 10.3748/wjg.v17.i12.1606

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

Review 1.  Hepatic manifestations of autoimmune rheumatic diseases.

Authors:  S Abraham; S Begum; D Isenberg
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

2.  Panoramic nailfold capillaroscopy: a new reading method and normal range.

Authors:  L E Andrade; A Gabriel Júnior; R L Assad; A J Ferrari; E Atra
Journal:  Semin Arthritis Rheum       Date:  1990-08       Impact factor: 5.532

Review 3.  Immunopathogenesis of systemic sclerosis.

Authors:  B White
Journal:  Rheum Dis Clin North Am       Date:  1996-11       Impact factor: 2.670

4.  Endothelin-1 plays a major role in portal hypertension of biliary cirrhotic rats through endothelin receptor subtype B together with subtype A in vivo.

Authors:  H Kojima; S Sakurai; S Kuriyama; H Yoshiji; H Imazu; M Uemura; Y Nakatani; J Yamao; H Fukui
Journal:  J Hepatol       Date:  2001-06       Impact factor: 25.083

5.  Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis.

Authors:  H Fujii; M Hasegawa; K Takehara; N Mukaida; S Sato
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

6.  Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases.

Authors:  Nathalie Ganne-Carrié; Marianne Ziol; Victor de Ledinghen; Catherine Douvin; Patrick Marcellin; Laurent Castera; Daniel Dhumeaux; Jean-Claude Trinchet; Michel Beaugrand
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

7.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

8.  Spleen enlargement on follow-up evaluation: a noninvasive predictor of complications of portal hypertension in cirrhosis.

Authors:  Annalisa Berzigotti; Paola Zappoli; Donatella Magalotti; Carolina Tiani; Valentina Rossi; Marco Zoli
Journal:  Clin Gastroenterol Hepatol       Date:  2008-07-10       Impact factor: 11.382

Review 9.  Caveolin-1, transforming growth factor-beta receptor internalization, and the pathogenesis of systemic sclerosis.

Authors:  Francesco Del Galdo; Michael P Lisanti; Sergio A Jimenez
Journal:  Curr Opin Rheumatol       Date:  2008-11       Impact factor: 5.006

10.  Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.

Authors:  M Cutolo; C Pizzorni; M Tuccio; A Burroni; C Craviotto; M Basso; B Seriolo; A Sulli
Journal:  Rheumatology (Oxford)       Date:  2004-03-16       Impact factor: 7.580

View more
  4 in total

Review 1.  Liver-spleen axis: intersection between immunity, infections and metabolism.

Authors:  Giovanni Tarantino; Antonella Scalera; Carmine Finelli
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

2.  Shear wave elastography (SWE) of the spleen in patients with hepatitis B and C but without significant liver fibrosis.

Authors:  Aleksander Pawluś; Marcin Inglot; Mariusz Chabowski; Kinga Szymańska; Małgorzata Inglot; Mateusz Patyk; Joanna Słonina; Filipe Caseiro-Alves; Dariusz Janczak; Urszula Zaleska-Dorobisz
Journal:  Br J Radiol       Date:  2016-08-16       Impact factor: 3.039

Review 3.  Splenomegaly in Children and Adolescents.

Authors:  Meinolf Suttorp; Carl Friedrich Classen
Journal:  Front Pediatr       Date:  2021-07-09       Impact factor: 3.418

4.  Spleen dynamic contrast-enhanced magnetic resonance imaging as a new method for staging liver fibrosis in a piglet model.

Authors:  Li Zhou; Tian-wu Chen; Xiao-ming Zhang; Cheng-jun Li; Zhen-feng Yang; Nan-lin Zeng; Li-ying Wang; Ting Li; Dan Wang; Jie Li; Chun-ping Li; Li Li; Xian-yong Xie
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.